Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Recruiting patients for Phase I oncology studies — which are unlikely to provide therapeutic benefit to participants and which carry the risk of significant side effects — raises unique issues in informed consent.

Helping researchers with a tough topic